The article on alteplase and anistreplase (28 December 1989, page 101) noted under ‘Unwanted effects’ that microemboli from disintegration of pre-existing clot are very dangerous, and suggested that ‘patients likely to have a pre-existing blood clot should not receive thrombolytic therapy’. A reader has convinced us that this advice could do harm, and we accept his arguments.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.